The SARS-CoV-2 homotrimeric spike (S) protein is the key antigen to target in a COVID-19 vaccine [12] since it mediates host cell infection by binding to the angiotensin-converting enzyme 2 (ACE2) [13,14]. This evidence concerns the gene ACE2 and COVID-19.